HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-06-20FDA Approved: DESCOVY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for DESCOVY (emtricitabine and tenofovir alafenamide) submitted by Gilead, updating the product labe…
-
FDA approval · 2025-06-20FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for TYBOST (cobicistat) submitted by Gilead Sciences.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults [Phase 1]
Phase 1 study to evaluate the pharmacokinetics, safety, and tolerability of Cabotegravir Ultra Long-acting (CAB ULA) after switching from Ca…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: SHARE Program: SUSTAIN [NA]
This clinical trial update notes an HIV infection study under the SHARE Program: SUSTAIN, sponsored by Florida State University, currently r…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Supporting Young Women's Reproductive Health by Harnessing Prosociality Among Drug Shopkeepers [NA]
This clinical trial evaluated whether leveraging drug shopkeepers’ prosocial behavior could improve reproductive health outcomes for young w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-06-18FDA Approved: YEZTUGO — Original Application (Gilead Sciences, Inc.)
FDA approved YEZTUGO (lenacapavir sodium) from Gilead as an original application for the treatment of HIV-1 infection in adults with multidr…
-
FDA approval · 2025-06-18FDA Approved: YEZTUGO — Original Application (Gilead Sciences, Inc.)
The FDA approved YEZTUGO (lenacapavir sodium) via an original application for the treatment of HIV-1 infection in adults with limited treatm…
-
EMA approval · 2025-06-18EMA Authorised: Atazanavir Viatris (previously Atazanavir Mylan) (atazanavir (as sulfate)) — Viatris Limited
EMA authorised Atazanavir Viatris (atazanavir sulfate) for HIV infections; Viatris Limited is the marketing authorization holder.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Telehealth for Pain and Unhealthy Drinking Among PLWH [NA]
ClinicalTrials.gov reports an ongoing Boston University trial evaluating telehealth interventions for managing pain and unhealthy alcohol us…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments [NA]
This clinical trial, sponsored by San Diego State University, aims to reduce hazardous alcohol use and optimize adherence to antiretroviral …
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Alignment of PrEP Use With HIV Risk in Young Women and Men [Phase 4]
Phase 4 study examining alignment of pre-exposure prophylaxis (PrEP) use with HIV risk among young women and men; the trial is completed and…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women
A completed clinical trial evaluating feminizing hormone therapy and its effects on the rectal mucosal immune environment in transgender wom…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) [NA]
This study investigates kidney transplantation from HIV-infected donors and assesses rejection rates and long-term outcomes in recipients. I…
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Piloting a Smartphone App to Improve Treatment Adherence Among South African Adolescents Living With HIV [NA]
This update describes the completion of a pilot trial testing a smartphone app intended to improve treatment adherence in South African adol…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection [NA]
This clinical trial update describes ongoing enrollment for a study evaluating annual couple-based HIV testing and counseling (CHTC) retesti…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Piloting a Biomarker-augmented Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program Among HIV-affected Adolescents and Young Adults in Zambia [NA]
A pilot study in Zambia is testing a biomarker-informed alcohol screening, brief intervention, and referral to treatment program for HIV-aff…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples [NA]
This clinical trial evaluates a couples-based motivational interviewing approach to reduce drug use and HIV risk among vulnerable male coupl…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY [NA]
A recruiting clinical trial in Zambia investigating person-centered approaches to managing HIV viremia and engagement among people with HIV …
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services [NA]
This Yale University study is recruiting to test a stepped-care approach that combines contingency management with PrEP adherence and suppor…
-
FDA approval · 2025-06-12FDA Approved: DELSTRIGO — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for DELSTRIGO, Merck's fixed-dose combination HIV-1 therapy (doravirine/lamivudine/tenofovir disopro…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Zinc Effect on Inflammation and Cardiovascular Risk in HIV [EARLY_Phase 1]
Early-phase 1 trial evaluating zinc supplementation for its effects on inflammation and cardiovascular risk in HIV-associated inflammation, …
-
FDA approval · 2025-06-12FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumara…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Vaccine Immunity and Inflammation in the Aging Person Living With HIV [Phase 4]
A Phase 4 clinical trial is studying vaccine-induced immunity and inflammation in aging adults living with HIV and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study [Phase 4]
A Phase 4 Vanguard study evaluates uptake and adherence to daily oral PrEP for HIV prevention among young African women, with results posted…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully [Phase 2]
This Phase 2 trial is evaluating maintenance antiretroviral therapy with DOR/3TC versus DTG/3TC in people living with HIV-1 infection; the s…